News
-
-
-
PRESS RELEASE
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Napo Pharmaceuticals announced the acceptance of an abstract on crofelemer powder study for SBS-IF at ACG 2026. Napo focuses on global crofelemer development for rare IF diseases -
-
-
PRESS RELEASE
LionVolt opens Flight One early access to UAV OEMs
LionVolt launches Flight One early access program for high-energy cell technology for UAV OEMs, offering enhanced endurance, range, and payload capacity. Lithium-metal cells with 400 Wh/kg energy and 5C discharge rates. Supply chain based in Europe -
-
-
PRESS RELEASE
Rapport financier semestriel 2026
-